AI assistant
Sight Sciences, Inc. — Director's Dealing 2025
Nov 6, 2025
33763_dirs_2025-11-06_a43085cf-9d0a-4d02-ad8b-3f8cb8da1836.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Sight Sciences, Inc. (SGHT)
CIK: 0001531177
Period of Report: 2025-11-05
Reporting Person: Rodberg James (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 146026 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $10.96 | 2031-05-24 | Common Stock (27500) | Direct | |
| Stock Option (Right to Buy) | $17.52 | 2032-02-08 | Common Stock (13100) | Direct | |
| Stock Option (Right to Buy) | $9.78 | 2033-03-16 | Common Stock (14400) | Direct |
Footnotes
F1: Includes (i) 28,252 shares of Common Stock, and (ii) 117,774 restricted stock units which are subject to vesting conditions.
F2: These options were granted on May 25, 2021 and became exercisable as to 25% of the underlying securities May 16, 2022, with the remainder vesting in 36 substantially equal installments on a monthly basis thereafter, subject to the Reporting Person's continued service to the Company through each such date.
F3: These options were granted on February 9, 2022 and vest in 48 substantially equal installments on a monthly basis commencing February 1, 2022, subject to the Reporting Person's continued service to the Company through each such date.
F4: These options were granted on March 16, 2023 and vest in 48 substantially equal installments on a monthly basis commencing February 1, 2023, subject to the Reporting Person's continued service to the Company through each such date.